BET bromodomain protein inhibition is a therapeutic option for medulloblastoma.

Oncotarget · 2013 · PMC3875771 · PMID 24231268

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

Thus, JQ1 treatment led to a highly significant increase in survival in the treatment group (Fig. 7B ).

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.